India’s Supreme Court questions 10x hospital markup on cancer drug
The Economic Times reports that a cancer drug costing Rs 2,700 sells for Rs 27,000 at hospitals. The court asked the Centre to examine a uniform 16% margin on all medicines.
TLDR
The Economic Times reports that India’s Supreme Court questioned a 10x hospital markup on a cancer drug costing Rs 2,700 and selling for Rs 27,000. The court also asked the Centre to examine a uniform 16% margin on all medicines and sought scrutiny of hospitals that require patients to buy drugs from in-house pharmacies.
Combined views
2.8K
1 Source, first seen 1h ago